Mark J Giganti

1.6k total citations
42 papers, 824 citations indexed

About

Mark J Giganti is a scholar working on Infectious Diseases, Virology and Emergency Medicine. According to data from OpenAlex, Mark J Giganti has authored 42 papers receiving a total of 824 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Infectious Diseases, 14 papers in Virology and 13 papers in Emergency Medicine. Recurrent topics in Mark J Giganti's work include HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (14 papers) and HIV-related health complications and treatments (13 papers). Mark J Giganti is often cited by papers focused on HIV/AIDS Research and Interventions (31 papers), HIV Research and Treatment (14 papers) and HIV-related health complications and treatments (13 papers). Mark J Giganti collaborates with scholars based in United States, Zambia and Mexico. Mark J Giganti's co-authors include Jeffrey S. A. Stringer, H. Benjamin, Elizabeth M. Stringer, Namwinga Chintu, John R. Koethe, Mohammed Limbada, Bryan E. Shepherd, Stewart E. Reid, Lloyd Mulenga and Albert Mwango and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Mark J Giganti

38 papers receiving 802 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark J Giganti United States 17 539 233 200 195 170 42 824
Bonaventura C. T. Mpondo Tanzania 19 370 0.7× 218 0.9× 132 0.7× 175 0.9× 127 0.7× 48 759
Tracy Creek United States 12 541 1.0× 247 1.1× 114 0.6× 208 1.1× 95 0.6× 14 733
Rose J. Kosgei Kenya 15 392 0.7× 247 1.1× 95 0.5× 270 1.4× 112 0.7× 41 901
Denna Michael Tanzania 17 402 0.7× 302 1.3× 88 0.4× 182 0.9× 76 0.4× 27 777
Patrick Coffié Ivory Coast 20 771 1.4× 630 2.7× 215 1.1× 152 0.8× 260 1.5× 73 1.2k
Patricia Agaba Nigeria 19 658 1.2× 443 1.9× 116 0.6× 140 0.7× 135 0.8× 73 1.1k
Sanjana Bhardwaj South Africa 15 530 1.0× 256 1.1× 81 0.4× 197 1.0× 106 0.6× 27 753
Megan Landes Canada 16 381 0.7× 249 1.1× 149 0.7× 175 0.9× 46 0.3× 47 771
Rhoderick Machekano United States 20 741 1.4× 474 2.0× 135 0.7× 237 1.2× 289 1.7× 84 1.7k
Katie Tayler‐Smith Luxembourg 19 370 0.7× 256 1.1× 144 0.7× 172 0.9× 62 0.4× 49 886

Countries citing papers authored by Mark J Giganti

Since Specialization
Citations

This map shows the geographic impact of Mark J Giganti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark J Giganti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark J Giganti more than expected).

Fields of papers citing papers by Mark J Giganti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark J Giganti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark J Giganti. The network helps show where Mark J Giganti may publish in the future.

Co-authorship network of co-authors of Mark J Giganti

This figure shows the co-authorship network connecting the top 25 collaborators of Mark J Giganti. A scholar is included among the top collaborators of Mark J Giganti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark J Giganti. Mark J Giganti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jilg, Nikolaus, Mark J Giganti, Kara W Chew, et al.. (2024). SARS-CoV-2 Plasma Antibody and Nucleocapsid Antigen Status Predict Outcomes in Outpatients With COVID-19. Clinical Infectious Diseases. 79(4). 920–927.
3.
Kapetanovic, Suad, Mark J Giganti, Mark J. Abzug, et al.. (2021). Plasma biomarker factors associated with neurodevelopmental outcomes in children with perinatal HIV infection and controlled viremia. AIDS. 35(9). 1375–1384. 7 indexed citations
4.
Belaunzarán-Zamudio, Pablo F., Yanink Caro‐Vega, Mark J Giganti, et al.. (2020). Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America. PLoS ONE. 15(6). e0233965–e0233965. 15 indexed citations
5.
Giganti, Mark J, Bryan E. Shepherd, Paula M. Luz, et al.. (2019). The impact of data quality and source data verification on epidemiologic inference: a practical application using HIV observational data. BMC Public Health. 19(1). 1748–1748. 9 indexed citations
6.
Wolff, Marcelo, Mark J Giganti, Claudia P. Cortés, et al.. (2017). A decade of HAART in Latin America: Long term outcomes among the first wave of HIV patients to receive combination therapy. PLoS ONE. 12(6). e0179769–e0179769. 13 indexed citations
7.
Giganti, Mark J, Paula M. Luz, Carina César, et al.. (2015). A Comparison of Seven Cox Regression-Based Models to Account for Heterogeneity Across Multiple HIV Treatment Cohorts in Latin America and the Caribbean. AIDS Research and Human Retroviruses. 31(5). 496–503. 10 indexed citations
8.
Koethe, John R., Elliot Marseille, Mark J Giganti, et al.. (2014). Estimating the cost-effectiveness of nutrition supplementation for malnourished, HIV-infected adults starting antiretroviral therapy in a resource-constrained setting. Cost Effectiveness and Resource Allocation. 12(1). 10–10. 5 indexed citations
9.
Stringer, Jeffrey S. A., Kathryn Stinson, Pius Tih, et al.. (2013). Measuring Coverage in MNCH: Population HIV-Free Survival among Children under Two Years of Age in Four African Countries. PLoS Medicine. 10(5). e1001424–e1001424. 25 indexed citations
10.
Benjamin, H., Mohammed Limbada, Mark J Giganti, et al.. (2012). Nonvirologic Algorithms for Predicting HIV Infection Among HIV-exposed Infants Younger Than 12 Weeks of Age. The Pediatric Infectious Disease Journal. 32(2). 151–156. 4 indexed citations
11.
Giganti, Mark J, et al.. (2011). Predictors of CD4 Eligibility for Antiretroviral Therapy Initiation Among HIV-Infected Pregnant Women in Lusaka, Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(5). e101–e105. 5 indexed citations
12.
Stringer, Elizabeth M., Bellington Vwalika, Mark J Giganti, et al.. (2011). Determinants of Stillbirth in Zambia. Obstetrics and Gynecology. 117(5). 1151–1159. 40 indexed citations
13.
Benjamin, H., Albert Mwango, Mark J Giganti, et al.. (2011). Comparative Outcomes of Tenofovir-Based and Zidovudine-Based Antiretroviral Therapy Regimens in Lusaka, Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 58(5). 475–481. 15 indexed citations
14.
Benjamin, H., Bellington Vwalika, Mark J Giganti, et al.. (2011). Implementation of the Zambia Electronic Perinatal Record System for comprehensive prenatal and delivery care. International Journal of Gynecology & Obstetrics. 113(2). 131–136. 37 indexed citations
15.
Benjamin, H., Albert Mwango, Mark J Giganti, et al.. (2010). Early Clinical and Programmatic Outcomes with Tenofovir-Based Antiretroviral Therapy in Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 54(1). 63–70. 55 indexed citations
16.
17.
Koethe, John R., Mohammed Limbada, Mark J Giganti, et al.. (2010). Early immunologic response and subsequent survival among malnourished adults receiving antiretroviral therapy in Urban Zambia. AIDS. 24(13). 2117–2121. 31 indexed citations
18.
Benjamin, H., Mark J Giganti, Mohammed Limbada, et al.. (2009). CD4+ Response and Subsequent Risk of Death Among Patients on Antiretroviral Therapy in Lusaka, Zambia. JAIDS Journal of Acquired Immune Deficiency Syndromes. 52(1). 125–131. 16 indexed citations
19.
Stringer, Elizabeth M., Mark J Giganti, Rosalind J. Carter, et al.. (2009). Hormonal contraception and HIV disease progression: a multicountry cohort analysis of the MTCT-Plus Initiative. AIDS. 23(Suppl 1). S69–S77. 26 indexed citations
20.
Das, Bibhu Ranjan, et al.. (2006). Age, Sex, and HIV Seroprevalence among Individuals from Different Parts of India Tested for HIV Infection in a Nongovernmental Setting. AIDS Research and Human Retroviruses. 22(11). 1067–1073. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bonaventura C. T. Mpondo Breakdown of academic impact, for papers by Tracy Creek Breakdown of academic impact, for papers by Rose J. Kosgei Breakdown of academic impact, for papers by Denna Michael Breakdown of academic impact, for papers by Patrick Coffié Breakdown of academic impact, for papers by Patricia Agaba Breakdown of academic impact, for papers by Sanjana Bhardwaj Breakdown of academic impact, for papers by Megan Landes Breakdown of academic impact, for papers by Rhoderick Machekano Breakdown of academic impact, for papers by Katie Tayler‐Smith
Rankless by CCL
2026